四唑融合咪唑并吡啶的设计、合成和生物学研究

IF 5.5 3区 材料科学 Q2 CHEMISTRY, MULTIDISCIPLINARY
Banoth Reddy, Amit Kumar Taneja, Mandava Bhuvan Tej, Komati Navya Sri, Mandava Bhagya Tej, Suryadevara Vijayavardhini, Dandamudi Srilaxmi, Somasekhar Tiruveedhula, Srinivasa Rao Penumutchu, Mandava V. Basaveswara Rao
{"title":"四唑融合咪唑并吡啶的设计、合成和生物学研究","authors":"Banoth Reddy,&nbsp;Amit Kumar Taneja,&nbsp;Mandava Bhuvan Tej,&nbsp;Komati Navya Sri,&nbsp;Mandava Bhagya Tej,&nbsp;Suryadevara Vijayavardhini,&nbsp;Dandamudi Srilaxmi,&nbsp;Somasekhar Tiruveedhula,&nbsp;Srinivasa Rao Penumutchu,&nbsp;Mandava V. Basaveswara Rao","doi":"10.1007/s42823-023-00603-2","DOIUrl":null,"url":null,"abstract":"<div><p>New tetrazole fused imidazopyridine derivatives <b>(12a–j)</b> were developed to exploit their cytotoxic activity towards cancer cell lines-MCF7, A549, and MDA-MB-231, utilizing MTT reduction assay with doxorubicin as standard drug. The compounds <b>12 h</b> and <b>12j</b> demonstrated strong anticancer activity bearing IC<sub>50</sub> values 1.44 µM and 1.33 µM against A549 cell line.</p><h3>Graphical abstract</h3>\n<div><figure><div><div><picture><img></picture></div></div></figure></div></div>","PeriodicalId":506,"journal":{"name":"Carbon Letters","volume":"34 1","pages":"41 - 49"},"PeriodicalIF":5.5000,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Design, synthesis and biological studies of tetrazole fused imidazopyridines\",\"authors\":\"Banoth Reddy,&nbsp;Amit Kumar Taneja,&nbsp;Mandava Bhuvan Tej,&nbsp;Komati Navya Sri,&nbsp;Mandava Bhagya Tej,&nbsp;Suryadevara Vijayavardhini,&nbsp;Dandamudi Srilaxmi,&nbsp;Somasekhar Tiruveedhula,&nbsp;Srinivasa Rao Penumutchu,&nbsp;Mandava V. Basaveswara Rao\",\"doi\":\"10.1007/s42823-023-00603-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>New tetrazole fused imidazopyridine derivatives <b>(12a–j)</b> were developed to exploit their cytotoxic activity towards cancer cell lines-MCF7, A549, and MDA-MB-231, utilizing MTT reduction assay with doxorubicin as standard drug. The compounds <b>12 h</b> and <b>12j</b> demonstrated strong anticancer activity bearing IC<sub>50</sub> values 1.44 µM and 1.33 µM against A549 cell line.</p><h3>Graphical abstract</h3>\\n<div><figure><div><div><picture><img></picture></div></div></figure></div></div>\",\"PeriodicalId\":506,\"journal\":{\"name\":\"Carbon Letters\",\"volume\":\"34 1\",\"pages\":\"41 - 49\"},\"PeriodicalIF\":5.5000,\"publicationDate\":\"2023-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Carbon Letters\",\"FirstCategoryId\":\"88\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s42823-023-00603-2\",\"RegionNum\":3,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Carbon Letters","FirstCategoryId":"88","ListUrlMain":"https://link.springer.com/article/10.1007/s42823-023-00603-2","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

利用以多柔比星为标准药物的 MTT 还原试验,开发了新的四唑融合咪唑吡啶衍生物 (12a-j),以开发其对癌症细胞系--MCF7、A549 和 MDA-MB-231 的细胞毒性活性。化合物 12 h 和 12j 对 A549 细胞株具有很强的抗癌活性,其 IC50 值分别为 1.44 µM 和 1.33 µM。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Design, synthesis and biological studies of tetrazole fused imidazopyridines

Design, synthesis and biological studies of tetrazole fused imidazopyridines

Design, synthesis and biological studies of tetrazole fused imidazopyridines

New tetrazole fused imidazopyridine derivatives (12a–j) were developed to exploit their cytotoxic activity towards cancer cell lines-MCF7, A549, and MDA-MB-231, utilizing MTT reduction assay with doxorubicin as standard drug. The compounds 12 h and 12j demonstrated strong anticancer activity bearing IC50 values 1.44 µM and 1.33 µM against A549 cell line.

Graphical abstract

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Carbon Letters
Carbon Letters CHEMISTRY, MULTIDISCIPLINARY-MATERIALS SCIENCE, MULTIDISCIPLINARY
CiteScore
7.30
自引率
20.00%
发文量
118
期刊介绍: Carbon Letters aims to be a comprehensive journal with complete coverage of carbon materials and carbon-rich molecules. These materials range from, but are not limited to, diamond and graphite through chars, semicokes, mesophase substances, carbon fibers, carbon nanotubes, graphenes, carbon blacks, activated carbons, pyrolytic carbons, glass-like carbons, etc. Papers on the secondary production of new carbon and composite materials from the above mentioned various carbons are within the scope of the journal. Papers on organic substances, including coals, will be considered only if the research has close relation to the resulting carbon materials. Carbon Letters also seeks to keep abreast of new developments in their specialist fields and to unite in finding alternative energy solutions to current issues such as the greenhouse effect and the depletion of the ozone layer. The renewable energy basics, energy storage and conversion, solar energy, wind energy, water energy, nuclear energy, biomass energy, hydrogen production technology, and other clean energy technologies are also within the scope of the journal. Carbon Letters invites original reports of fundamental research in all branches of the theory and practice of carbon science and technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信